BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9828023)

  • 21. Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay.
    Casonato A; Fabris F; Pontara E; Cattini MG; Zocca N; Gallinaro L; Girolami A; Pagnan A
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):296-304. PubMed ID: 16959682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapse of thrombotic thrombocytopenic purpura associated with decreased VWF cleaving activity.
    Anstadt MP; Carwile JM; Guill CK; Conklin LD; Soltero ER; Lucci A; Kroll MH
    Am J Med Sci; 2002 May; 323(5):281-4. PubMed ID: 12018674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Von Willebrand factor regulates complement on endothelial cells.
    Noone DG; Riedl M; Pluthero FG; Bowman ML; Liszewski MK; Lu L; Quan Y; Balgobin S; Schneppenheim R; Schneppenheim S; Budde U; James P; Atkinson JP; Palaniyar N; Kahr WH; Licht C
    Kidney Int; 2016 Jul; 90(1):123-34. PubMed ID: 27236750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
    Budde U; Schneppenheim R
    Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombosis and von Willebrand Factor.
    Shahidi M
    Adv Exp Med Biol; 2017; 906():285-306. PubMed ID: 27628010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Von Willebrand factor: molecular size and functional activity.
    Furlan M
    Ann Hematol; 1996 Jun; 72(6):341-8. PubMed ID: 8767102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
    Tsai HM
    J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
    Moake JL
    Annu Rev Med; 2002; 53():75-88. PubMed ID: 11818464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
    Mannucci PM; Lombardi R; Lattuada A; Ruggenenti P; Viganò GL; Barbui T; Remuzzi G
    Blood; 1989 Aug; 74(3):978-83. PubMed ID: 2665869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine.
    Moake JL; Rudy CK; Troll JH; Schafer AI; Weinstein MJ; Colannino NM; Hong SL
    Am J Hematol; 1985 Sep; 20(1):73-9. PubMed ID: 3875285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    George JN
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):627-32. PubMed ID: 16167049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indications for a protective function of beta2-glycoprotein I in thrombotic thrombocytopenic purpura.
    Du VX; van Os G; Kremer Hovinga JA; Dienava-Verdoold I; Wollersheim J; Ruggeri ZM; Fijnheer R; de Groot PG; de Laat B
    Br J Haematol; 2012 Oct; 159(1):94-103. PubMed ID: 22881339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Zhou Z; Nguyen TC; Guchhait P; Dong JF
    Semin Thromb Hemost; 2010 Feb; 36(1):71-81. PubMed ID: 20391298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A perspective on the measurement of ADAMTS13 in thrombotic thrombocytopaenic purpura.
    Pimanda JE; Chesterman CN; Hogg PJ
    Eur J Haematol; 2003 Apr; 70(4):257-62. PubMed ID: 12656756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond.
    Lian EC
    Semin Thromb Hemost; 2005 Dec; 31(6):625-32. PubMed ID: 16388413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased platelet retention in familial recurrent thrombotic thrombocytopenic purpura.
    Karpman D; Holmberg L; Jirgård L; Lethagen S
    Kidney Int; 1996 Jan; 49(1):190-9. PubMed ID: 8770967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. von Willebrand factor abnormalities and endothelial cell perturbation in a patient with acute thrombotic thrombocytopenic purpura.
    Moake JL; Rudy CK; Troll JH; Weinstein MJ; Colannino NM; Hong SL; Koutcher JA; Melaragno AJ; Manner CE
    Am J Med Sci; 1986 Jan; 291(1):47-50. PubMed ID: 3079954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. alpha 1-Antitrypsin therapy in a case of thrombotic thrombocytopenic purpura.
    Galbusera M; Ruggenenti P; Noris M; Burnouf-Radosevich M; Benigni A; Mannucci PM; Remuzzi G
    Lancet; 1995 Jan; 345(8944):224-5. PubMed ID: 7823715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Baker KR; Moake JL
    Curr Opin Pediatr; 2000 Feb; 12(1):23-8. PubMed ID: 10676770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.